SNCA and Parkinson disease: LRRK2 is a serine/threonine kinase, PD-causing mutations enhancing its activity and contributing to neurodegeneration [170] by modulating inflammatory activity and oxidative stress in microglia exposed to fibrillar α-synuclein aggregates [171].